Debanjan Ray, Chief Financial Officer at CytomX Therapeutics, Inc. (CTMX), sold 3,000 shares at $26.05 ($78K) on 2018-08-01, disclosed to the SEC on 2018-08-02.
Open-market sale of $78k CTMX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTMX | SELL | 2018-10-02 | $55K | — | Filing → |
| CTMX | SELL | 2018-09-06 | $67K | — | Filing → |
| CTMX | SELL | 2018-07-03 | $68K | — | Filing → |